Страна: Армения
Язык: английский
Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
isoniazid
Macleods Pharmaceuticals Ltd.
J04AC01
isoniazid
300mg
tablets
(672/24x28/) in blister
Prescription
Registered
2016-10-06
Isoniazid 100 mg/Isoniazid 300 mg Tablets (Macleods Pharmaceuticals Ltd), TB178/TB179 WHOPAR part 4 September 2011 Section 6 updated : March 2016 Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS Isoniazid 100 mg/Isoniazid 300 mg Tablets (Macleods Pharmaceuticals Ltd), TB178/TB179 WHOPAR part 4 September 2011 Section 6 updated : March 2016 Page 2 of 11 1. NAME OF THE MEDICINAL PRODUCT Isoniazid 100 mg Tablets * Isoniazid 300 mg Tablets * 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Isoniazid 100 mg or 300 mg For a full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Isoniazid 100 mg Tablets: White to off-white, circular, biconvex, uncoated tablets with breakline on one side and plain surface on the other side. Isoniazid 100 mg Tablets can be divided into equal halves. Isoniazid 300 mg Tablets: White, circular, biconvex, uncoated tablets having plain surface on both the sides. Isoniazid 300 mg Tablets should not be divided or crushed. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATION Isoniazid Tablets is indicated for the treatment of tuberculosis, caused by _Mycobacterium _ _tuberculosis._ The most recent official guidelines on the treatment of tuberculosis (e.g. WHO guideline: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf _) _ should be taken into consideration for deciding on the appropriateness of therapy with Isoniazid Tablets. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral use. Isoniazid Tablets should be swallowed whole with water or another drink. The tablets should be taken on an empty stomach (at least one hour prior to or two hours after a meal). ACTIVE TUBERCULOSIS For the treatment of active tuberculosis isoniazid must always be used in combination with other antituberculosis drugs Daily therapy: In children 10mg/kg/day (range 10 to 15 mg/kg body weight/day), in adults 5 mg (range 4-6 mg/kg body weight/day) * Trade names are not prequalified by WHO. This is under local DRA responsibility. Throughout this WHOPAR the proprietary name is given as an examp Прочитать полный документ